Staphylococcus

Staphylococcus. This genus of Gram-positive bacteria is characterized by its spherical cells that typically form grapelike clusters. Members of this genus are ubiquitous, found on the skin and mucous membranes of humans and many animals, and are a leading cause of both community-acquired and hospital-associated infections. While many species are harmless commensal organisms, several are significant opportunistic pathogens, with Staphylococcus aureus being the most clinically notorious due to its array of virulence factors and antibiotic resistance.

Description and classification

Staphylococci are non-motile, non-spore-forming facultative anaerobes that appear as cocci under microscopic examination, often arranged in irregular clusters resembling grapes. They are catalase-positive, a key test that distinguishes them from the streptococci. The genus was first described in 1884 by the German surgeon Friedrich Julius Rosenbach. Classification within the genus is complex, with over 50 species and subspecies identified, primarily through techniques like 16S ribosomal RNA sequencing and DNA–DNA hybridization. Major species include the coagulase-positive S. aureus and coagulase-negative species such as Staphylococcus epidermidis, a common skin commensal, and Staphylococcus saprophyticus, associated with urinary tract infections. Other notable species include Staphylococcus lugdunensis and Staphylococcus haemolyticus.

Pathogenesis and virulence factors

Pathogenicity varies widely among species and is mediated by a formidable arsenal of surface components and secreted toxins. A critical feature is the production of coagulase, an enzyme that clots plasma, which is a hallmark of S. aureus. Key virulence factors include surface proteins that promote adherence to host tissues, such as fibronectin-binding proteins and clumping factor. Many strains produce a polysaccharide capsule or the surface protein Protein A, which inhibits phagocytosis. Potent exotoxins include panton-valentine leukocidin, toxic shock syndrome toxin-1, and a family of enterotoxins responsible for food poisoning. The ability to form biofilm on medical devices like catheters and prosthetic joints is a major virulence mechanism for coagulase-negative staphylococci like S. epidermidis.

Clinical significance

Staphylococci cause a vast spectrum of diseases, ranging from minor skin infections like folliculitis, furuncles, and impetigo to life-threatening conditions such as bacteremia, endocarditis, osteomyelitis, pneumonia, and septic arthritis. S. aureus is a predominant cause of surgical site infections and soft tissue infections. Specific toxin-mediated illnesses include toxic shock syndrome, scalded skin syndrome, and gastroenteritis. Coagulase-negative staphylococci are increasingly recognized as pathogens, particularly in healthcare settings, causing bloodstream infections associated with intravascular catheters and infections of prosthetic heart valves and cerebrospinal fluid shunts.

Diagnosis and treatment

Diagnosis relies on culturing the organism from clinical specimens like blood cultures, wound swabs, or abscess aspirates. Colonies on media like blood agar are often hemolytic and pigmented (e.g., golden for S. aureus). Identification involves Gram stain, catalase testing, coagulase testing, and automated systems like the VITEK 2. Antibiotic susceptibility testing is crucial due to high resistance rates. Treatment is complicated by widespread resistance; many strains produce penicillinase, rendering penicillin ineffective. Of grave concern is methicillin-resistant Staphylococcus aureus, which requires alternative agents like vancomycin, daptomycin, or linezolid. Management often involves incision and drainage of abscesses alongside antimicrobial therapy.

Epidemiology and prevention

Staphylococci are globally distributed, with humans as the primary reservoir for many pathogenic species. S. aureus colonizes the anterior nares of approximately 30% of the population. Transmission occurs via direct contact or through fomites. MRSA has evolved from a strictly nosocomial problem to a cause of community-associated MRSA infections. Prevention in healthcare settings centers on contact precautions, hand hygiene compliance with alcohol-based hand sanitizer, proper aseptic technique, and decolonization protocols for high-risk patients using mupirocin or chlorhexidine. Research into vaccine development, such as those targeting the capsular polysaccharide, has been ongoing but with limited clinical success to date.

Category:Bacteria